Published online Jul 9, 2022. doi: 10.5409/wjcp.v11.i4.341
Peer-review started: January 7, 2022
First decision: March 9, 2022
Revised: March 23, 2022
Accepted: June 3, 2022
Article in press: June 3, 2022
Published online: July 9, 2022
Processing time: 179 Days and 20.4 Hours
Pediatric inflammatory bowel disease in a region of Brazil.
The pediatric inflammatory bowel disease data are practically unknown in Brazil and South America.
To determine the epidemiology of pediatric inflammatory bowel disease and its characteristics in Brazil and South America.
The data were retrieved from the Public Medication-Dispensing System of the Department of Health in Espírito Santo state of Brazil.
The prevalence and incidence in pediatric ages are higher than those in other regions in Latin America. More severe disease was observed in the youngest patients. Pancolitis is more frequent in ulcerative colitis, and fistulizing and perianal disease are more frequent in Crohn's disease. Use of biological therapy was compared in the pediatric and adult groups.
We have little data on inflammatory bowel disease in Latin America. We need to better understand the epidemiology, phenotype and medication used for the treatment of inflammatory bowel disease in each region.
Obtain better therapeutic approaches and contribute to the planning of public health actions.